The scrip was listed at Rs 144, a 4.35% premium to the initial public offer (IPO) price. The stock is currently up 4.48% over ...

Investor participation was enthusiastic across all categories. Overall, the issue was subscribed to 144.5 times, driven ...

The initial public offer of Wakefit Innovations was subscribed 2.52 times. The offer received bids 9.16 crore shares as against 3.63 crore shares on offer. The issue opened for bidding on 8 December ...

Mumbai: Shares of Corona Remedies, a well-known pharmaceutical company, made an impressive entry into the stock market on ...

KV Toys India made a strong stock market debut on Monday, listing at a 34% premium on the BSE SME platform. The Rs ...

KV Toys India made a strong stock market debut on Monday, listing at a 34% premium on the BSE SME platform. The Rs ...

Wakefit Innovations listed flat on Monday, debuting at Rs 195 on the NSE and slightly lower on the BSE, in line with muted ...

Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1,452 on BSE.

Despite a solid premium, K.V. Toys India IPO listing missed expectations as signalled by the grey market premium (GMP). K.V.

Wakefit Innovations sold its shares in the price band of Rs 185-195 apiece, applied for a minimum of 76 shares and its ...

The company’s IPO, worth Rs 655.37 crore, is entirely an offer-for-sale of 62 lakh shares. The price band for the Corona ...

Corona Remedies made a strong market debut on December 15, with shares listed at ₹1,461 on NSE and ₹1,452 on BSE, reflecting premiums of 37.57% and 36.72% respectively. The IPO was highly subscribed, ...